Programmed cell death protein 1 (PD-1) blockade induces an anti-tumor response by inhibiting the PD-1/programmed death-ligand 1 (PD-L1) checkpoint that blocks the effector functions of anti-tumor T cells [6]. The gene discussed is PDCD1; the disease is neoplasm.